Share this
Trajan’s Mitra Microsampling Devices and Kits Receive IVD Registration in Australia
by Neoteryx Microsampling on July 25,2023
July 2023 — Trajan Scientific and Medical, a leader in analytical and life sciences products, has registered its Neoteryx remote blood microsampling Mitra® devices and Mitra® Sample Collection Kits under a new manufacturing label.
The Mitra is classified as a Class I in vitro diagnostic (IVD) medical device by the Therapeutic Goods Administration (TGA) in Australia, while the Mitra® Sample Collection Kit is now classified as a Class IIa medical device for home use.
The regulatory update allows Trajan's Mitra microsampling products to be used in a wider range of settings, including clinical facilities and home environments, to promote telehealth and personalized medicine. This will be especially beneficial for doctors and researchers who want to increase clinical trial participation, therapeutic drug monitoring and remote routine health checks, amongst Australia's rural communities, non-traditional participants, and individuals with limited access to clinical facilities.
The Mitra Sample Collection Kits can simply be mailed to these populations for self-guided specimen collection.
Using the Mitra device is a game-changer for individuals participating in clinical studies who are averse to blood draws or are unable to make it to a clinic for a blood draw. It's very easy to use and requires only a quick finger-stick method, making it accessible to virtually anyone.
Once the sample is collected, the patient or study participant can simply send it to the lab using the provided specimen bag and envelope in the home kit.
The microsamples integrate with laboratory analysis workflows, as shown in previous studies conducted by pharmaceutical companies, healthcare organizations, and academic research institutions around the world. As published in the literature, specimens collected with Mitra Kits have been used to study inflammatory biomarkers, PSA for prostate cancer screenings, antibodies against SARS-CoV-2, and more.
“The updated regulatory registration of Trajan’s Mitra microsampling devices in Australia increases our ability to facilitate personalized, preventative data-based healthcare,” said Stephen Tomisich, CEO and founder, Trajan. “Our Mitra microsampling solutions allow almost anyone to take an analytically viable sample in or out of a clinical setting, anytime, anywhere.”
About Trajan Scientific and Medical
Trajan is a global developer and manufacturer of analytical and life sciences products and devices founded to enrich personal health through scientific tools and solutions. We aim to support science that benefits people. Trajan’s products and solutions are used in the analysis of biological, food, and environmental samples. Trajan has a portfolio and pipeline of new technologies which support the move towards decentralized personalized data-based healthcare.
Trajan comprises more than 680 people with seven manufacturing sites across the US, Australia, Europe, and Malaysia, and operations in Australia, the US, Asia, and Europe. Trajan’s products and solutions are marketed under multiple product brands, including Neoteryx, serving a range of industries in countries around the world. For more information, visit www.trajanscimed.com.
About Neoteryx, Microsampling Solutions by Trajan
Neoteryx, a world leader in microsampling devices, was acquired by Trajan in 2021. Today, Trajan’s microsampling solutions carry the Neoteryx brand. The Neoteryx range of microsampling products provide precise, quantitative remote specimen collection. They are easy to use and amenable to automated analysis in the lab, easing workflows and enabling decentralized research and healthcare models.
The product portfolio includes the Mitra® device based on VAMS® technology and the hemaPEN® that advances both capillary and dried blood spot (DBS) technologies, with more microsampling products in the pipeline. For more information on Trajan’s Neoteryx range of microsampling solutions, visit www.neoteryx.com.
Related Stories in the News: https://www.medicaldevice-network.com/news/trajan-blood-microsampling-devices-uk/
Image Credits: Trajan, Neoteryx
Share this
- Microsampling (40)
- Industry News, Microsampling News (33)
- Mitra® Device (33)
- Company Press Release, Product Press Release (21)
- Research, Remote Research (17)
- Infectious Disease, Vaccines, COVID-19 (15)
- Clinical Trials, Clinical Research (14)
- Blood Microsampling, Serology (10)
- Biomonitoring, Health, Wellness (9)
- Decentralized Clinical Trial (DCT) (8)
- Omics, Multi-Omics (7)
- Venipuncture Alternative (6)
- Specimen Collection (3)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (3)
- Harpera® Tool (2)
- Pharmaceuticals, Drug Development (2)
- Skin Microsampling, Microbiopsy (2)
- Therapeutic Drug Monitoring, TDM (2)
- Antibodies, MAbs (1)
- Environmental Toxins, Exposures (1)
- Preclinical Research, Animal Studies (1)
- hemaPEN® Device (1)
- August 2024 (1)
- May 2024 (2)
- January 2024 (1)
- December 2023 (2)
- November 2023 (3)
- October 2023 (2)
- September 2023 (1)
- August 2023 (3)
- July 2023 (3)
- June 2023 (1)
- May 2023 (2)
- April 2023 (1)
- March 2023 (2)
- February 2023 (1)
- January 2023 (2)
- December 2022 (1)
- November 2022 (1)
- October 2022 (2)
- August 2022 (1)
- April 2022 (1)
- February 2022 (1)
- January 2022 (1)
- December 2021 (1)
- November 2021 (1)
- October 2021 (2)
- September 2021 (1)
- August 2021 (2)
- July 2021 (2)
- June 2021 (2)
- April 2021 (1)
- March 2021 (2)
- February 2021 (1)
- January 2021 (1)
- December 2020 (1)
- November 2020 (1)
- October 2020 (1)
- September 2020 (2)
- August 2020 (3)
- July 2020 (3)
- June 2020 (2)
- May 2020 (1)
- April 2020 (3)
- October 2019 (1)
- March 2019 (1)
- January 2019 (1)
- November 2018 (1)
- August 2018 (1)
- July 2018 (1)
- June 2017 (1)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- May 2016 (1)
- December 2015 (1)
- October 2015 (1)
- August 2015 (1)
- August 2014 (1)
- July 2014 (1)
No Comments Yet
Let us know what you think